Allain, T J, Bearn, J A, Coskeran, P et al. · Biological psychiatry · 1997 · DOI
This study looked at hormone levels in people with ME/CFS compared to healthy controls. Researchers found that ME/CFS patients had lower levels of two growth-related hormones (IGF-I and IGF-II), a weaker response to a hormone stimulation test, higher insulin levels, and lower levels of a protein that regulates these hormones. These differences suggest the hormone system that controls growth and metabolism may work differently in ME/CFS.
Understanding hormonal dysfunction in ME/CFS may help explain the mechanism of fatigue and exercise intolerance. If GH-IGF axis abnormalities are primary pathological features, they could become targets for treatment. This work opens investigation into neuroendocrine causes rather than purely psychiatric explanations of ME/CFS.
This study does not establish whether the observed hormone abnormalities cause ME/CFS symptoms or result from them. The cross-sectional design cannot determine causality, and the authors themselves note that reduced physical activity in CFS could explain the findings rather than a primary disease mechanism. The study does not prove these abnormalities are treatable or that correcting them would improve symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →